Independent since 2023  ·  No affiliate links.  ·  We buy every subscription ourselves. New York, NYIssue No. 148
Home / Reviews / Sleepio
SleepCBT-IDigital therapeutic

Sleepio review: the most rigorously tested app in consumer health

Six weeks through the digital CBT-I programme with 26 clinical trials behind it, 18 of them randomised. This is the highest score we have ever given, and the reason is boring: somebody did the work.

Short answer

If you can get Sleepio, get it. It delivers CBT-I — the guideline first-line treatment for chronic insomnia, ahead of medication — and has been evaluated in 26 clinical trials including 18 RCTs and a placebo-controlled trial, with reported clinical improvement in 76% of patients. Access is usually via employer, health plan or prescription.

14 min read
88
out of 100
The verdict

If you can get it, get it. That conditional is the only real criticism.

Sleepio delivers cognitive behavioural therapy for insomnia — the first-line treatment in major clinical guidelines, ahead of medication — through a fully automated programme evaluated in 26 clinical trials including 18 RCTs and a placebo-controlled trial. Reported clinical improvement runs to 76% of patients. It scores 88 rather than higher only because most people can't simply buy it.

How we tested. Bought at retail with our own money and used through a full test cycle, with pricing verified against Sleepio's own site on 1 September 2026. No advance notice to the company, no copy approval, no affiliate relationship — we earn nothing if you buy it. Full methodology.

Not medical advice. Nothing here diagnoses or treats a condition, and none of it replaces a clinician who knows your history. Results and programmes are a starting point for a conversation, not a substitute for one.

The score, axis by axis

Measurement validity9.0
Evidence & claims9.8
Data rights8.8
Daily UX8.6
Price & value9.2
Staying power7.4

Composite = mean of six axes × 10, rounded. Axis weights are equal by design; see methodology. Current price: Usually via employer, health plan or prescription (SleepioRx).

What we liked

  • 26 clinical trials including 18 randomised controlled trials
  • A placebo-controlled RCT — a standard almost nothing in consumer health meets
  • Reported clinical improvement in 76% of patients, sustained at six months in recent work
  • Delivers the guideline first-line treatment for chronic insomnia, not sleep tracking
  • Frequently free to the user through an employer or health plan

What we didn't

  • Hard to obtain if your employer or insurer doesn't offer it
  • No human coach — the programme is fully automated
  • Requires real behavioural commitment, including sleep restriction, which is uncomfortable
  • Not a fit if insomnia is secondary to pain, breathing problems or medication
  • Sparse consumer-facing pricing, because you're usually not the buyer

Why CBT-I is the thing to look for

Before anything about this app: cognitive behavioural therapy for insomnia is the recommended first-line treatment for chronic insomnia in major clinical guidelines, ahead of sleeping medication. It works by changing sleep scheduling, stimulus control and the thinking that keeps people awake.

It is also chronically inaccessible, because there are nowhere near enough trained therapists. That gap is the entire reason digital CBT-I exists, and it's why this app belongs in a different conversation from the sleep trackers sitting beside it in the app store. Meta-analyses of digital CBT-I consistently find improvements in self-reported sleep parameters.

The evidence, which is the point

26 clinical trials. 18 randomised controlled trials. A placebo-controlled RCT. Reported clinical improvement in insomnia for 76% of patients, with gains sustained at six months in recent work on the prescription version.

For scale: the most-studied meditation app in our database has 14 RCTs, half of them carrying a company conflict of interest. The best-validated sleep wearable rests on a single 96-person validation study. Nothing else we review is in this territory, and our Evidence & claims axis at 9.8 is the highest we have awarded anything.

A 2025 nationwide decentralised RCT published in JMIR Mental Health tested digital CBT-I in US adults and found it effective, with gains holding at six months.

Eighteen randomised controlled trials, including a placebo-controlled one. We do not get to write that sentence about anything else.

What the programme is actually like

Uncomfortable, and that's a feature. CBT-I involves sleep restriction — deliberately compressing time in bed to rebuild sleep pressure — and the first fortnight makes you more tired, not less. Our tester found week two genuinely hard and week five transformative, which is the documented shape of this treatment.

The programme is fully automated, delivered as weekly sessions with a virtual therapist, and it does not have a human coach. For a technique that asks you to do something counterintuitive while exhausted, the absence of a person to reassure you is the strongest argument for the alternatives — see our comparison with Sleep Reset.

The access problem

Here is the criticism that costs it points. Sleepio reaches people primarily through employers, health plans, and in its SleepioRx form via prescription. It is not really a thing you buy on a Tuesday because you had a bad week.

The practical sequence: check your employer's benefits portal, then ask your clinician about SleepioRx. A large number of people who would benefit already have access and don't know it. If both routes are dead ends, an app you cannot obtain has an effectiveness of zero for you specifically — and free CBT-I workbooks, or the CBT-i Coach app originally built for veterans, use the same technique at no cost.

What it doesn't do

It doesn't track your sleep in any way you'd find interesting, and that's correct. Measuring insomnia does not treat insomnia, and for a meaningful group of people, nightly sleep scores add performance anxiety to a bed — the exact opposite of what this programme is trying to undo.

It also isn't the right tool if your insomnia is secondary to untreated pain, sleep-disordered breathing or a medication side effect. Those need a clinician first.

Who should use it

  • Use it if your employer, health plan or prescriber can give you access — take it, it usually costs you nothing.
  • Use it if you've had trouble sleeping for months and want the treatment rather than the measurement.
  • Consider Sleep Reset if you can't get Sleepio and want a human coach.
  • See a clinician first if pain, breathing or medication may be driving the insomnia.

The bottom line

Sleepio earns 88/100 — the highest score in our database. It delivers the treatment clinical guidelines actually recommend, with an evidence base nothing else in consumer health approaches. The only thing standing between it and a higher score is that most people can't simply go and buy it.

Sources

Hannah Weiss

Reviews Editor — Sleep & Mind

PhD in chronobiology. Runs Applandica's home polysomnography bench and reads the studies in the footer so you don't have to.

Corrections & updates. None yet. We re-test every app every 12 months or every two major releases, whichever comes first, and publish any score change here, dated and signed.